Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Lung Neoplasms 4Colorectal Neoplasms 4Stomach Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Wilms Tumor 1Venous Thromboembolism 1Uveal Melanoma 1Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1Smoking Cessation 1Recurrence 1Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Neoplastic Cells, Circulating 1Motor Activity 1Melanoma 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1Hepatic Veno-Occlusive Disease 1HPV Positive Oropharyngeal Squamous Cell Carcinoma 1Fibrosis 1Esophageal Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colonic Neoplasms 1Cardiovascular Diseases 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Rivaroxaban 3apixaban 2Heparin, Low-Molecular-Weight 2Fondaparinux 2Enoxaparin 2Dalteparin 2enoxaparin sodium 1edoxaban 1Warfarin 1Tinzaparin 1Nadroparin 1Long-Term Synaptic Depression 1Hematologic Tests 1Educational Status 1Dabigatran 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Venous Thromboembolism × Hematologic Tests × Clear all
NCT01608919 2015-08-10

Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection

University of Colorado, Denver

Phase NA Terminated
4 enrolled
Classical hematology

Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡